(Z)-5-((5-phenylthiophen-2-yl)methylene)-4-thioxothiazolidin-2-one | 1401235-31-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: (Z)-5-((5-phenylthiophen-2-yl)methylene)-4-thioxothiazolidin-2-one
• 英文别名: (5Z)-5-[(5-phenylthiophen-2-yl)methylidene]-4-sulfanylidene-1,3-thiazolidin-2-one
• CAS: 1401235-31-1
• 化学式: C₁₄H₉NOS₃
• 分子量: 303.43
• InChiKey: KKMBBTIZENIADR-WQLSENKSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  115
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  5-苯基-2-噻吩甲醛 、 4-硫代噻唑烷-2-酮 在 sodium acetate 、 溶剂黄146 作用下， 反应 2.0h， 以65%的产率得到(Z)-5-((5-phenylthiophen-2-yl)methylene)-4-thioxothiazolidin-2-one
  参考文献：
  名称：

  5-Arylidenethioxothiazolidinones as Inhibitors of Tyrosyl–DNA Phosphodiesterase I

  摘要：

  Tyrosyl-DNA phosphodiesterase I (Tdp1) is a cellular enzyme that repairs the irreversible topoisomerase I (Top1)-DNA complexes and confers chemotherapeutic resistance to Top1 inhibitors. Inhibiting Tdp1 provides an attractive approach to potentiating clinically used Top1 inhibitors. However, despite recent efforts in studying Tdp1 as a therapeutic target, its inhibition remains poorly understood and largely underexplored. We describe herein the discovery of arylidene thioxothiazolidinone as a scaffold for potent Tdp1 inhibitors based on an initial tyrphostin lead compound 8. Through structure-activity relationship (SAR) studies we demonstrated that arylidene thioxothiazolidinones inhibit Tdp1 and identified compound 50 as a submicromolar inhibitor of Tdp1 (IC50 = 0.87 mu M). Molecular modeling provided insight into key interactions essential for observed activities. Some derivatives were also active against endogenous Tdp1 in whole cell extracts. These findings contribute to advancing the understanding on Tdp1 inhibition.

  DOI：

  10.1021/jm3008773

文献信息

• [EN] THIOXOTHIAZOLIDINONE DERIVATIVES USEFUL AS INHIBITORS OF TDP1<br/>[FR] DÉRIVÉS DE THIOXOTHIAZOLIDINONES UTILES EN TANT QU'INHIBITEURS DE TDP1
  申请人：US HEALTH

  公开号：WO2013055771A1

  公开（公告）日：2013-04-18

  Tdp1 inhibitors of Formula (I) and methods of using those inhibitors to treat cancer are provided in this disclosure. R1 is hydrogen or lower alkyl and G is a substituted phenyl or optionally substituted heteroaryl group. The disclosed Tdp1 inhibitors may be used alone to treat cancer, but may also be used in combination with another active agent, such as camptothecin or a camptothecin analogue.

  本公开提供的是公式（I）的Tdp1抑制剂及其用于治疗癌症的方法。其中，R1为氢或低碳基，G为取代苯基或可选取代的杂环芳基基团。所披露的Tdp1抑制剂可单独用于治疗癌症，也可与另一种活性剂（例如喜树碱或喜树碱类似物）联合使用。